Analystreport

Jounce Therapeutics, Inc. (NASDAQ: JNCE) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating.

Jounce Therapeutics, Inc.  (JNCE) 
Last jounce therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.jouncetx.com